Integrative Proteomic Characterization of Pancreatic Ductal Adenocarcinoma

Clinical trial NCT04525209 · UNKNOWN

Trial details

NCT number: NCT04525209
Sponsor: Ruijin Hospital
Status: UNKNOWN
Study type: OBSERVATIONAL

Tumor Tissues and Non-tumor Tissues From PDAC Patients Were Used for Genomic and Transcriptome Sequencing Analysis and Proteomics and Phosphorylated Proteomics

Start date: 2020-10-01
Primary completion: 2022-12-31
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.